Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Lunai Bioworks Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −8 vs. Q1 2023
- Shares held
- 1.85M
- −1.45M (−44.0%) vs. Q1 2023
- Total value
- $1.13M
- −$1.90M (−62.7%) vs. Q1 2023
- New holders
- 6
- 4 more added
- Sold out
- 14
- 21 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Houlihan Financial Resource Group, Ltd. | 201,500 | $193.0K | 0.01% | +201,500 | New |
| BlackRock Inc. | 252,757 | $143.2K | 0.00% | −979,227−79.5% | Reduced |
| Millennium Management LLC | 251,478 | $142.5K | 0.00% | +214,704+583.8% | Added |
| Vanguard Group Inc | 227,029 | $128.6K | 0.00% | −95,247−29.6% | Reduced |
| Geode Capital Management, LLC | 155,861 | $88.3K | 0.00% | −162,994−51.1% | Reduced |
| Goldman Sachs Group Inc | 118,105 | $66.9K | 0.00% | +104,273+753.9% | Added |
| Natixis | 100,000 | $56.7K | 0.00% | +40,276+67.4% | Added |
| Jane Street Group, LLC | 83,128 | $47.1K | 0.00% | +83,128 | New |
| Susquehanna International Group, LLP | 56,298 | $31.9K | 0.00% | +42,885+319.7% | Added |
| State Street Corp | 52,087 | $29.5K | 0.00% | −255,321−83.1% | Reduced |
| Morgan Stanley | 46,361 | $26.3K | 0.00% | −29,273−38.7% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 43,219 | $24.5K | 0.00% | +43,219 | New |
| Two Sigma Advisers, LP | 33,200 | $18.8K | 0.00% | −23,200−41.1% | Reduced |
| Old Mission Capital LLC | 32,262 | $18.3K | 0.00% | +32,262 | New |
| Two Sigma Investments, LP | 31,023 | $17.6K | 0.00% | −25,129−44.8% | Reduced |
| Deutsche Bank AG | 29,648 | $16.8K | 0.00% | −20,006−40.3% | Reduced |
| Qube Research & Technologies Ltd | 29,235 | $16.6K | 0.00% | +29,235 | New |
| Northern Trust Corp | 26,908 | $15.2K | 0.00% | −136,645−83.5% | Reduced |
| Blair William & Co | 26,000 | $14.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 12,734 | $7.21K | 0.00% | −8−0.1% | Reduced |
| Virtu Financial LLC | 11,029 | $6.00K | 0.00% | +11,029 | New |
| Bank of New York Mellon Corp | 10,529 | $5.97K | 0.00% | −44,476−80.9% | Reduced |
| JPMorgan Chase & Co | 7,126 | $4.04K | 0.00% | −8,012−52.9% | Reduced |
| Rhumbline Advisers | 5,517 | $3.13K | 0.00% | −24,981−81.9% | Reduced |
| BNP Paribas Arbitrage, SA | 3,395 | $1.92K | 0.00% | −6,736−66.5% | Reduced |
| Bank of America Corp | 1,781 | $1.01K | 0.00% | −27,212−93.9% | Reduced |
| FMR LLC | 828 | $469 | 0.00% | −3,373−80.3% | Reduced |
| Wells Fargo & Company | 487 | $276 | 0.00% | −2,986−86.0% | Reduced |
| New York State Common Retirement Fund | 200 | $113 | 0.00% | −30,800−99.4% | Reduced |
| Citigroup Inc | 3 | $2 | 0.00% | −753−99.6% | Reduced |
| Group One Trading, L.P. | 1 | $1 | 0.00% | −68−98.6% | Reduced |
| Royal Bank of Canada | 709 | $0 | 0.00% | −964−57.6% | Reduced |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −121,513−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −100,950−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −43,414−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −38,712−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −12,650−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,543−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −9,819−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −9,537−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −7,369−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −7,347−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −3,821−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,653−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,482−100.0% | Sold out |